Movement Alert|AXT Inc Rises 6.28% in Regular Trading, Q2 Earnings Inflection and Indium Phosphide Supply Shortage Continue to Fuel Rally

Market Focus
Aug 17

On August 17, AXT Inc rose 6.28% in regular trading, trading at $88.17 per share, with turnover of approximately $80.99 million. The stock extended its recent rebound as the market continued to digest the Q2 earnings beat and persistent indium phosphide (InP) supply-demand tightness.

AXT reported Q2 adjusted EPS of $0.19, beating the consensus estimate of $0.07 by over 170%, while revenue surged 165% year-over-year to $47.6 million versus estimates of $34.1 million. InP substrate revenue reached a record $30.7 million in the quarter, with adjusted gross margin jumping from 8.2% a year ago to 45.0%. Management characterized the quarter as a business inflection point rather than a one-quarter step-up. Wedbush maintained its outperform rating, noting the company's leadership in IP, manufacturing capacity, and technical capability positions it to capitalize on the AI-fueled opportunity.

At the industry level, the global InP substrate supply-demand gap exceeds 70%, with AI data center connectivity requirements continuing to drive fundamental improvement expectations.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10